Many commonly used drugs are typically effective in only 40-60% of the patient population, but still substantial number of subjects experience serious adverse reactions and death directly related to drug use. Personalized medicine uses genomic and molecular data to better target the delivery of healthcare by helping to determine individual patient’s response to certain therapies.
Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.
Sep 19, 2019
Jun 3, 2019
|Medycyna personalizowana - nowa era diagnostyki i farmakoterapii||Sep 19, 2019|
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Kaliszan, Roman Długokęcka, Justyna
Lubiatowska-Krysiak, Eliza Twardowski, Tomasz
Schmitt, Claudia Stencel, Dariusz